lentinan has been researched along with picibanil in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (48.15) | 18.7374 |
| 1990's | 7 (25.93) | 18.2507 |
| 2000's | 6 (22.22) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, T; Mai, M; Natsuume-Sakai, S; Omote, K | 1 |
| Endoh, F; Fujimoto, S; Masuda, Y; Obata, G; Ohno, K; Takahashi, M; Takai, M | 1 |
| Abe, Y; Horiuchi, A; Kimura, S; Miyake, M; Miyazaki, T | 1 |
| Obi, Y | 1 |
| Hisamura, M | 1 |
| Niizu, Y; Urushizaki, I | 1 |
| Isono, K; Ochiai, T | 1 |
| Akimoto, M; Mori, S; Nishihira, T | 2 |
| Hosoe, S; Ogura, T | 1 |
| Akimoto, M; Kasai, M; Nishihira, T | 1 |
| Abe, S; Mizuno, D; Takahashi, K; Yamazaki, M | 1 |
| Abe, R; Akimoto, M; Ewasaki, H; Kasai, M; Matano, S; Nakajima, Y; Ueki, H | 1 |
| Oguro, M; Takagi, T; Takenaga, K; Yanagawa, T | 1 |
| Ishida, N; Matsubara, S; Suzuki, F; Suzuki, M | 1 |
| Chihara, G; Hamuro, J; Maeda, YY | 1 |
| Abe, R; Akimoto, M; Kasai, M | 1 |
| Abe, S; Mizuno, D; Takahashi, K; Tsubouchi, J; Yamazaki, M | 1 |
| Fukuda, S; Moriya, N; Sakata, Y; Sasaki, D; Suto, T; Watanabe, Y; Yoshida, Y | 1 |
| Kunieda, K; Saji, S; Sugiyama, Y; Umemoto, T | 1 |
| Chijiiwa, K; Kuroiwa, T; Morisaki, T; Nakamura, K; Noshiro, H; Ogawa, T; Tanaka, M; Uchiyama, A; Yamanaka, N | 1 |
| Kunieda, K; Saji, S; Sugiyama, Y | 1 |
| Cho, YK; Choi, JH; Joo, HJ; Kim, HC; Kim, HS; Kim, MW; Lee, KB; Lim, HY; Yi, JW | 1 |
| Ebina, T | 1 |
| Hazama, S; Kawaoka, T; Oka, M; Tangoku, A; Yoshino, S | 1 |
| Hazama, S; Kawaoka, T; Kondo, H; Oka, M; Yamamoto, K; Yoshino, S | 1 |
| Hazama, S; Maeda, K; Maeda, N; Maeda, Y; Oka, M; Yoshida, S; Yoshino, S | 1 |
4 review(s) available for lentinan and picibanil
| Article | Year |
|---|---|
[Antineoplastic mechanism of immunotherapy in neoplastic cells].
Topics: Animals; Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; BCG Vaccine; Biological Products; Humans; Immunotherapy; Interleukin-2; Lentinan; Neoplasms; Picibanil; T-Lymphocytes | 1986 |
Current status and perspectives of immunomodulators of microbial origin.
Topics: Adjuvants, Immunologic; Animals; Bacteria; BCG Vaccine; Blood Proteins; Carbohydrate Conformation; Chemical Phenomena; Chemistry; Colonic Neoplasms; Fungi; Glucans; Humans; Immunotherapy; Infections; Lentinan; Lymphocytes; Macrophage Activation; Neoplasms, Experimental; Picibanil; Polysaccharides; Proteoglycans; Rectal Neoplasms; Sizofiran; Stomach Neoplasms; Structure-Activity Relationship | 1982 |
[Recent progress in biological therapies for cancer].
Topics: Antibodies, Monoclonal; BCG Vaccine; Humans; Immunologic Factors; Immunotherapy, Adoptive; Interferons; Lentinan; Neoplasms; Picibanil; Proteoglycans | 1999 |
[Immunochemotherapy for cancer patients of the stomach--cancer therapy keeping with good host-immunocompetency].
Topics: Adjuvants, Immunologic; Clinical Trials as Topic; Combined Modality Therapy; Humans; Immunocompetence; Lentinan; Picibanil; Proteoglycans; Stomach Neoplasms | 2001 |
4 trial(s) available for lentinan and picibanil
| Article | Year |
|---|---|
[Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
Topics: Animal Nutritional Physiological Phenomena; Animals; Antineoplastic Agents; Biological Products; Humans; Interleukin-2; Lentinan; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nutritional Physiological Phenomena; Picibanil; Polysaccharides; Stomach Neoplasms | 1988 |
[Anti-cancer effects of BRMs associated with nutrition in cancer patients].
Topics: Adjuvants, Immunologic; Animals; Esophageal Neoplasms; Humans; Lentinan; Mice; Mice, Inbred C3H; Neoplasms; Nutrition Disorders; Picibanil; Stomach Neoplasms | 1988 |
[Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
Topics: Animals; Combined Modality Therapy; Endocrine Glands; Female; Fluorouracil; Humans; Lentinan; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasms; Neoplasms, Experimental; Nutritional Physiological Phenomena; Picibanil; Stomach Neoplasms | 1986 |
Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Embolization, Therapeutic; Ethanol; Female; Fluorouracil; Humans; Immunologic Factors; Lentinan; Liver Neoplasms; Male; Middle Aged; Picibanil; Survival Rate | 1994 |
19 other study(ies) available for lentinan and picibanil
| Article | Year |
|---|---|
Evaluation of basic procedures for adoptive immunotherapy for gastric cancer.
Topics: Adult; Aged; Antigens, Surface; Cytotoxicity Tests, Immunologic; Female; Humans; Immunologic Factors; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Lentinan; Lymph Nodes; Lymphocytes; Male; Middle Aged; Phytohemagglutinins; Picibanil; Spleen; Stomach Neoplasms | 1992 |
Two-color flow cytometric analysis of splenic lymphocyte subpopulations in patients with gastric cancer.
Topics: Adult; Aged; Female; Flow Cytometry; Humans; Immunologic Factors; Lentinan; Male; Middle Aged; Neoplasm Staging; Picibanil; Spleen; Stomach Neoplasms; T-Lymphocyte Subsets | 1992 |
The endogenous induction of tumor necrosis factor serum (TNS) for the adjuvant postoperative immunotherapy of cancer--changes in immunological markers of the blood.
Topics: Aged; Antigens, CD; Biomarkers, Tumor; Carcinoma, Hepatocellular; CD4-Positive T-Lymphocytes; Esophageal Neoplasms; Female; Humans; Immunotherapy; Interferons; Lentinan; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Picibanil; Postoperative Period; Remission Induction; Stomach Neoplasms; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha | 1990 |
[Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
Topics: Adult; Aged; Female; Humans; Immunologic Factors; Injections, Intralesional; Interleukin-2; Lentinan; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Picibanil; Stomach Neoplasms; T-Lymphocyte Subsets; T-Lymphocytes | 1991 |
[A case of early gastric cancer disappeared by endoscopic polypectomy and local injection of anti-cancer agent associated with systemic immunochemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Gastroscopy; Humans; Immunotherapy; Injections; Lentinan; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur | 1990 |
[Immunotherapy].
Topics: Adjuvants, Immunologic; Glycoproteins; Growth Inhibitors; Humans; Interferons; Interleukin-2; Lentinan; Neoplasms; Picibanil; Proteoglycans; Tumor Necrosis Factor-alpha | 1986 |
[Clinical evaluation of BRMs in gastric cancer patients].
Topics: Adjuvants, Immunologic; Cell Wall Skeleton; Humans; Lentinan; Mucoproteins; Mycolic Acids; Picibanil; Stomach Neoplasms | 1988 |
Complete regression of Lewis lung carcinoma by cyclophosphamide in combination with immunomodulators.
Topics: Animals; Biological Products; Combined Modality Therapy; Cyclophosphamide; Hypersensitivity, Delayed; Immunotherapy; Lentinan; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Picibanil; Polysaccharides, Bacterial | 1985 |
[Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan)].
Topics: Animals; Cell Division; Cell Line; Female; Fluorouracil; Interferon Inducers; Interferons; Lentinan; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Picibanil; Poly I-C | 1984 |
[Direct antitumor activity of biological response modifiers (B.R.M.) proven by an in vitro sensitivity test].
Topics: Animals; Biological Products; Cell Division; Cell Survival; Cell Wall; Cells, Cultured; Drug Resistance; Lentinan; Leucine; Leukemia L1210; Leukemia, Experimental; Mice; Nocardia; Picibanil; Polysaccharides; Proteoglycans | 1984 |
The induction of viral inhibitor(s) in mice treated with biological and synthetic immunopotentiators.
Topics: Adjuvants, Immunologic; Animals; Dose-Response Relationship, Drug; Glycopeptides; Interferon Inducers; Interferons; Lentinan; Levamisole; Mice; Mice, Inbred Strains; Mycobacterium bovis; Picibanil; Poly I-C; Proteoglycans; Sizofiran | 1980 |
[Effects of protein calorie intake on immuno- and chemotherapy].
Topics: Animals; Dietary Proteins; Female; Fluorouracil; Killer Cells, Natural; Lentinan; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Picibanil; Protein-Energy Malnutrition | 1982 |
Combination therapy of murine tumors with lentinan, bacterial lipopolysaccharide and a Streptococcus preparation, OK432.
Topics: Animals; Biological Products; Complement System Proteins; Cytotoxicity, Immunologic; Hypersensitivity, Delayed; Lentinan; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C3H; Picibanil; Polysaccharides; Polysaccharides, Bacterial | 1983 |
[Seven patients with stage IVb advanced gastric cancer who were treated with preoperative chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Lentinan; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Picibanil; Preoperative Care; Prognosis; Stomach Neoplasms; Survival Analysis | 2000 |
Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorouracil; Gastrectomy; Humans; Immunotherapy; Lentinan; Life Tables; Male; Middle Aged; Mitomycin; Neoplasm Proteins; Picibanil; Stomach Neoplasms; Survival Analysis; Thymidylate Synthase | 2002 |
[Activation of antitumor immunity by intratumor injection of biological preparations].
Topics: Adjuvants, Immunologic; Agaricus; Animals; Antineoplastic Agents; Glucans; Immunologic Factors; Injections, Intralesional; Lentinan; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Picibanil; Proteoglycans | 2003 |
[Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Immunotherapy; Interferon-gamma; Interleukin-10; Interleukin-12; Lentinan; Male; Middle Aged; Picibanil; Pleural Effusion, Malignant; Stomach Neoplasms | 2003 |
[Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
Topics: Aged; Antineoplastic Agents; Ascitic Fluid; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-12; Lentinan; Male; Middle Aged; Peritoneal Cavity; Picibanil; Pleural Cavity; Pleural Effusion, Malignant | 2005 |
[Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion].
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Injections; Injections, Intraperitoneal; Lentinan; Male; Middle Aged; Picibanil; Pleural Cavity; Pleural Effusion, Malignant; Treatment Outcome | 2010 |